Dosimetric framework for therapeutic alpha-particle emitters

Journal of Nuclear Medicine

Volumn 38, Issue 12, 1997, Pages 1923-1929

  Roeske, John C ^a   Stinchcomb, Thomas G ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

Alpha particle emitters; Dosimetry; Microdosimetry; Radiation therapy

Indexed keywords

ALPHA RADIATION; ARTICLE; DOSIMETRY; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION ENERGY;

ALPHA PARTICLES; HUMANS; RADIATION DOSAGE; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, HIGH-ENERGY;

EID: 0031442829     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Rotmensch J, Atcher RW, Hines J, et al. The development of alpha-emitting radionuclide lead-212 for the potential treatment of ovarian carcinoma. Am J Obstet Gynecol 1989;160:789-797.
2. Rotmensch J, Atcher RW, Schlenker R, et al. The effect of alpha-emitting radionuclide lead 212 on human ovarian carcinoma: a potential new form of therapy. Gynecol Oncol 1989;32:236-239.
3. Rotmensch J, Atcher RW, Hines J, Toohill M, Herbst AL. Comparison of short-lived high-LET alpha-emitting radionuclide lead-212 and bismuth-212 to low-LET x-rays on ovarian carcinoma. Gynecol Oncol 1989;35:297-300.
4. Macklis RM, Kaplan WD, Ferrara JLM, et al. Alpha particle radioimmunotherapy: animal models and clinical perspectives. Int J Radiat Oncol Biol Phys 1988;16:1377-1387.
5. Macklis RM, Kinsey BM, Kassis AI, et al. Radioimmunotherapy with alpha-particle-emitting immunoconjugates. Science 1988;240:1024-1026.
6. Kozak RW, Atcher RW, Gansow OA, Friedman AM, Hines JJ, Waldman TA. Bismuth-212-labeled anti-TAC monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapy. Proc Natl Acad Sci USA 1986;83:474-478.
7. Kurtzman SH, Russo A, Mitchell JB, et al. Bismuth-212 linked to an antipancreatic carcinoma antibody: model for alpha-particle-emitter radioimmunotherapy. J Natl Cancer Inst 1988;80:449-452.
8. 212Bi) therapy. Cancer Res 1993;53:5683-5689.
9. 212Bi alpha particle irradiation. Nucl Med Biol 1993;20:795-805.
10. Geerlings MW, Kaspersen FM, Apostolidis C, van der Hout R. The feasibility of 225Ac as a source of alpha-particles in radioimmunotherapy. Nucl Med Commun 1993;14:121-125.
11. Macklis RM, Lin JY, Beresford B, Atcher RW, Hines JJ, Humm JL. Cellular kinetics, dosimetry, and radiobiology of alpha-particle radioimmunotherapy: induction of apoptosis. Radiat Res 1992;130:220-226.
12. Rotmensch J, Schwartz JL, Atcher RW, Harper PV, DeSombre E. Increased nuclear damage by high linear energy transfer radioisotopes applicable for radiodirected therapy against radiologie malignancies. Gynecol Obstet Invest 1991;32:180-184.
13. Hall EJ. Radiobiology for the radiologist, 2nd Ed. Hagerstown, MD: Harper and Row; 1978:65-77.
14. Polig, E. Localized alpha-dosimetry. In: Ebert M, Howards A, eds. Current topics in radiation research. Vol. 13. Amsterdam: North Holland; 1978:189-327.
15. Loevinger R, Budinger TF, Watson EE. MIRD primer for absorbed dose calculations, Revised. New York: The Society of Nuclear Medicine; 1991:1-22.
16. Goddu SM, Howell RW, Rao DV. Cellular dosimetry: absorbed fractions for monoenergetic electron and alpha-particle sources and S-values for radionuclides uniformly distributed in different cell compartments. J Nucl Med 1994;35:303-316.
17. Goddu SM, Howell RW, Buchet LG, Bolch WE, Rao D. MIRD cellular S values: self-absorbed dose per unit cumulated activity for selected radionuclides and monoenergetic electron and alpha particle emitters incorporated into different cell compartments. Reston, VA: The Society of Nuclear Medicine; 1997:2-14.
18. Humm JL. A microdosimetric model of astatine-211 labelled antibodies for radioimmunotherapy. Int J Radiat Oncol Biol Phys 1987;13:1767-1773.
19. Humm JL, Chin LM. A model of cell inactivation by alpha-particle internal emitters. Radiat Res 1993;134:143-150.
20. Charlton DE, Sephton R. A relationship between microdosimetric spectra and cell survival for high-LET irradiation. Int J Radiat Biol 1991;59:447-457.
21. Charlton DE, Kassis AI, Adelstein SJ. A comparison of experimental and calculated survival curves for V79 cells grown as monolayers or in suspension exposed to alpha irradiation from 212-Bi distributed in the growth medium. Radiat Prot Dosim 1994;52:311-315.
22. Humm JL, Roeske JC, Fisher DR, Chen GTY. Microdosimetric concepts in radioimmunotherapy. Med Phys 1993;20:535-541.
23. Roesch WC. Microdosimetry of internal sources. Radiat Res 1977;70:494-510.
24. Fisher DR. The microdosimetry of monoclonal antibodies labeled with alpha emitters. In: Schlafke-Stelson AT, Watson EE, eds. Proceedings of the fourth international radiopharmaceutical dosimetry symposium. Oak Ridge, TN: Oak Ridge Associated Universities; 1986:26-36.
25. Fisher DR, Harty R. The microdosimetry of lymphocytes irradiated by alpha particles. Int J Radiat Biol 1982;41:315-324.
26. Stinchcomb TG, Roeske JC. Analytic microdosimetry for radioimmunotherapeutic alpha emitters. Med Phys 1992;19:1385-1393.
27. Stinchcomb TG, Roeske JC. Survival of alpha-particle irradiated cells as a function of the shape and size of the sensitive volume (nucleus). Radiat Prot Dosim 1995;62:157-164.
28. Kellerer AM. Analysis of patterns of energy deposition; a survey of theoretical relations in microdosimetry. In: Ebert HG, ed. Proceedings of the second symposium on microdosimetry. Brussels: Commission of European Communities: 1970:107-134.
29. Roesch WC. Moments of microdosimetric quantities for particulate sources. Radiat Res 1985;102:392-398.
30. Caswell RS. Deposition of energy by neutrons in spherical cavities. Radiat Res 1996;27:92-107.
31. Kellerer AM, Chmelevsky D. Criteria for the applicability of LET. Radiat Res 1975;63:226-234.
32. Azure MT, Archer RD, Sastry KSR, Rao DV, Howell RW. Biological effects of lead-212 localized in the nucleus of mammalian cells: role of recoil energy in the radiotoxicity of internal alpha-particle emitters. Radiat Res 1994;140:276-283.
33. Howell RW, Rao DV, Hou D-Y, Narra VR, Sastry KSR. The question of relative biological effectiveness and quality factor for Auger emitters incorporated into proliferating mammalian cells. Radiat Res 1991;128:282-292.
34. ICRU. Stopping powers, ranges for protons, and alpha particles. International Commission of Radiation Units and Measurements Report No. 49. Bethesda, MD: ICRU; 1993:256.
35. Eckerman KF, Ryman JC, Taner AC, Kerr GD. Traversals of cells by radiation and absorbed fraction estimates for electrons and alpha particles. In. A. T. Schlafke-Stelson and E. E. Watson, eds. Proceedings of the fourth international radiopharmaceutical dosimetry symposium. Oak Ridge, TN: Oak Ridge Associated Universities; 1986:67-86.
36. ICRU. Microdosimetry, International Commission of Radiation Units and Measurements Report No. 36. Bethesda, MD: ICRU; 1983:54-55.